EDINBURGH, Scotland, Dec. 31, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T-cell therapies for cancer and other indications, today announced it has...
Read More Details
Finally We wish PressBee provided you with enough information of ( TCBP Provides Update on Acquisition Strategy and Current Targets )
Also on site :
- Petroleum Ministry activates emergency plan for natural gas supply
- Amazon Is Selling a 'Buttery Soft' $60 2-Piece Set for Just $30, and Shoppers Say It 'Feels Like Spanx Air Essentials'
- 7 Places to Visit in Barcelona for an Unforgettable First Trip, According to Nomadic Matt